Administration of recombinant erythropoietin to a patient with malignant lymphoma who refused blood transfusion

A 30-year-old female patient with malignant lymphoma was admitted to the hospital because of large mass in the left pelvic cavity and of severe anemia. Since she had refused blood transfusion (Jehovah's witness), recombinant human erythropoietin (Epo) was used together with both chemotherapy an...

Full description

Saved in:
Bibliographic Details
Published inRinshō ketsueki Vol. 31; no. 10; p. 1698
Main Authors Ushijima, A, Nishimura, H, Kawakita, M, Takatsuki, K
Format Journal Article
LanguageJapanese
Published Japan 01.10.1990
Subjects
Adult
Blood Transfusion
Christianity
Combined Modality Therapy
Erythropoietin - therapeutic use
Female
Humans
Lymphoma - radiotherapy
Lymphoma - therapy
Recombinant Proteins - therapeutic use
Online AccessGet more information

Cover

More Information
Summary:A 30-year-old female patient with malignant lymphoma was admitted to the hospital because of large mass in the left pelvic cavity and of severe anemia. Since she had refused blood transfusion (Jehovah's witness), recombinant human erythropoietin (Epo) was used together with both chemotherapy and irradiation; this led to rapid recovery of the anemia and marked reduction of the mass volume. These findings may suggest the possible application of Epo administration as a supportive therapy in treatment of malignancy.
ISSN:0485-1439
DOI:10.11406/rinketsu.31.1698